A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19
10.1016/j.kint.2021.07.016
Saved in:
Main Authors: | Da, Yi, Goh, Giap Hean, Khatri, Priyanka |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206701 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Severe thrombocytopenia, thrombosis and anti-PF4 antibody after Pfizer-BioNTech COVID-19 mRNA vaccine booster-Is it vaccine-induced Immune thrombotic thrombocytopenia?
by: Ling, Victor W. T., et al.
Published: (2023) -
Severe Thrombocytopenia, Thrombosis and Anti-PF4 Antibody after Pfizer-BioNTech COVID-19 mRNA Vaccine Booster—Is It Vaccine-Induced Immune Thrombotic Thrombocytopenia?
by: Lee, Shir Ying, et al.
Published: (2022) -
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
by: Notarte, Kin Israel, et al.
Published: (2022) -
Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)
by: Lin, Weiqin, et al.
Published: (2022) -
Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing
by: Siripipattanamongkol N.
Published: (2023)